Kao WY - Search Results

1

Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease.

Lu CH, Wang W, Li YJ, Chang IW, Chen CL, Su CW, Chang CC, Kao WY. Lu CH, et al. Among authors: kao wy. Obes Surg. 2024 Oct 25. doi: 10.1007/s11695-024-07548-z. Online ahead of print. Obes Surg. 2024. PMID: 39448457

2

Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.

Kao WY, Chang IW, Chen CL, Su CW, Fang SU, Tang JH, Chang CC, Chang YJ, Wang W. Kao WY, et al. Obes Surg. 2020 Apr;30(4):1249-1257. doi: 10.1007/s11695-019-04192-w. Obes Surg. 2020. PMID: 31953745

3

Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis.

Kao WY, Lin YF, Chang IW, Chen CL, Tang JH, Chang CC, Chang YJ, Wang W. Kao WY, et al. J Chin Med Assoc. 2021 Mar 1;84(3):261-266. doi: 10.1097/JCMA.0000000000000469. J Chin Med Assoc. 2021. PMID: 33306598

4

Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients.

Wu HC, Hsieh YR, Wang W, Chang CW, Chang IW, Chen CL, Chang CC, Chang CH, Kao WY, Huang SY. Wu HC, et al. Among authors: kao wy. J Clin Med. 2023 May 29;12(11):3730. doi: 10.3390/jcm12113730. J Clin Med. 2023. PMID: 37297926 Free PMC article.

5

The correlation between fatty liver disease and chronic kidney disease.

Chen PC, Kao WY, Cheng YL, Wang YJ, Hou MC, Wu JC, Su CW. Chen PC, et al. Among authors: kao wy. J Formos Med Assoc. 2020 Jan;119(1 Pt 1):42-50. doi: 10.1016/j.jfma.2019.02.010. Epub 2019 Mar 12. J Formos Med Assoc. 2020. PMID: 30876789 Free article.

6

Outcomes of atezolizumab and bevacizumab for hepatocellular carcinoma: Does age matter?

Kao WY, Su CW. Kao WY, et al. Liver Int. 2022 Dec;42(12):2597-2598. doi: 10.1111/liv.15434. Liver Int. 2022. PMID: 36415175 No abstract available.

7

A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.

Kao WY, Su CW, Chau GY, Lui WY, Wu CW, Wu JC. Kao WY, et al. World J Surg. 2011 Apr;35(4):858-67. doi: 10.1007/s00268-010-0928-z. World J Surg. 2011. PMID: 21207029

8

Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?

Chang WT, Kao WY, Chau GY, Su CW, Lei HJ, Wu JC, Hsia CY, Lui WY, King KL, Lee SD. Chang WT, et al. Among authors: kao wy. Surgery. 2012 Nov;152(5):809-20. doi: 10.1016/j.surg.2012.03.024. Epub 2012 Jul 3. Surgery. 2012. PMID: 22766361

9

Reply.

Kao WY, Tan EC, Su CW. Kao WY, et al. Hepatology. 2019 Jul;70(1):440-441. doi: 10.1002/hep.30632. Hepatology. 2019. PMID: 30927281 No abstract available.

10

Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver.

Chou TH, Yeh HJ, Chang CC, Tang JH, Kao WY, Su IC, Li CH, Chang WH, Huang CK, Sufriyana H, Su EC. Chou TH, et al. Among authors: kao wy. J Chin Med Assoc. 2021 Sep 1;84(9):842-850. doi: 10.1097/JCMA.0000000000000585. J Chin Med Assoc. 2021. PMID: 34282076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters